Armstrong Shaw Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Williams Companies
WMB
|
+$15.7M |
| 2 |
State Street
STT
|
+$7.43M |
| 3 |
Zimmer Biomet
ZBH
|
+$222K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$12.1M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$10.9M |
| 3 |
HP
HPQ
|
+$2.62M |
| 4 |
Dell
DELL
|
+$2.38M |
| 5 |
Microsoft
MSFT
|
+$1.84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.51% |
| 2 | Healthcare | 16.22% |
| 3 | Technology | 13.87% |
| 4 | Energy | 12.29% |
| 5 | Industrials | 10.86% |
Similar funds
Armstrong Shaw Associates's Q1 2017 Portfolio in Review
As of Q1 2017, Armstrong Shaw Associates held 47 positions worth $400M, down 4.9% from $421M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Armstrong Shaw Associates withdrew a net $35.7M in Q1 2017, closing 5 positions and reducing 28 holdings. Its most notable exit was Goldman Sachs, an estimated $12.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Armstrong Shaw Associates opened a new position in Williams Companies worth $16.1M.
- Armstrong Shaw Associates's largest Q1 2017 buy was Williams Companies: 542,536 shares worth $16.1M.
- Armstrong Shaw Associates's biggest Q1 2017 reduction was Microsoft, cutting an estimated $1.84M.
- Armstrong Shaw Associates fully exited Goldman Sachs in Q1 2017, selling an estimated $12.1M.
- Armstrong Shaw Associates's ten largest holdings make up 42% of its $400M portfolio in Q1 2017.
- Armstrong Shaw Associates opened 3 new positions and closed 5 in Q1 2017.
- Armstrong Shaw Associates's portfolio value fell 4.9% quarter-over-quarter to $400M.
Based on Armstrong Shaw Associates's 13F filing for Q1 2017, filed 27 Apr 2017.